8-K
Current Report
Mineralys Therapeutics, Inc. Filed Acc 0001933414-23-000076
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading mlys-20230912.htm…